Fingerprint
Dive into the research topics of 'Feasibility, phase I, and phase II studies of tandutinib, an oral platelet-derived growth factor receptor-β tyrosine kinase inhibitor, in patients with recurrent glioblastoma'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically